Work

Phase II study of bevacizumab in combination with cetuximab plus irinotecan in irinotecan-refractory colorectal cancer (CRC) patients who have progressed on a bevacizumab-containing regimen (The BOND 2.5 Study)

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.4087

Authors: N. H. Segal, D. Reidy-Lagunes, M. Capanu, N. Kemeny, K. Chung, D. Kelsen, E. Hollywood, N. Goodman-Davis, L. B. Saltz

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2257530665

Cites:

Cited by: 10

Related to: 10